202 related articles for article (PubMed ID: 20085584)
1. Altered expression of glycan genes in cancers induced by epigenetic silencing and tumor hypoxia: clues in the ongoing search for new tumor markers.
Kannagi R; Sakuma K; Miyazaki K; Lim KT; Yusa A; Yin J; Izawa M
Cancer Sci; 2010 Mar; 101(3):586-93. PubMed ID: 20085584
[TBL] [Abstract][Full Text] [Related]
2. Carbohydrate antigen sialyl Lewis a--its pathophysiological significance and induction mechanism in cancer progression.
Kannagi R
Chang Gung Med J; 2007; 30(3):189-209. PubMed ID: 17760270
[TBL] [Abstract][Full Text] [Related]
3. Altered sphingolipid metabolism induced by tumor hypoxia - new vistas in glycolipid tumor markers.
Yin J; Miyazaki K; Shaner RL; Merrill AH; Kannagi R
FEBS Lett; 2010 May; 584(9):1872-8. PubMed ID: 19913543
[TBL] [Abstract][Full Text] [Related]
4. Altered glycosylation in cancer: A promising target for biomarkers and therapeutics.
Thomas D; Rathinavel AK; Radhakrishnan P
Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188464. PubMed ID: 33157161
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic silencing of the synthesis of immunosuppressive Siglec ligand glycans by NF-κB/EZH2/YY1 axis in early-stage colon cancers.
Huang HC; Chao CC; Wu PH; Chung HY; Lee HY; Suen CS; Hwang MJ; Cai BH; Kannagi R
Biochim Biophys Acta Gene Regul Mech; 2019 Feb; 1862(2):173-183. PubMed ID: 30716533
[TBL] [Abstract][Full Text] [Related]
6. Current relevance of incomplete synthesis and neo-synthesis for cancer-associated alteration of carbohydrate determinants--Hakomori's concepts revisited.
Kannagi R; Yin J; Miyazaki K; Izawa M
Biochim Biophys Acta; 2008 Mar; 1780(3):525-31. PubMed ID: 17980710
[TBL] [Abstract][Full Text] [Related]
7. Glycan gene expression signatures in normal and malignant breast tissue; possible role in diagnosis and progression.
Potapenko IO; Haakensen VD; Lüders T; Helland A; Bukholm I; Sørlie T; Kristensen VN; Lingjaerde OC; Børresen-Dale AL
Mol Oncol; 2010 Apr; 4(2):98-118. PubMed ID: 20060370
[TBL] [Abstract][Full Text] [Related]
8. Omics-based Identification of Glycan Structures as Biomarkers for a Variety of Diseases.
Akiyoshi S; Iwata M; Berenger F; Yamanishi Y
Mol Inform; 2020 Jan; 39(1-2):e1900112. PubMed ID: 31622036
[TBL] [Abstract][Full Text] [Related]
9. Protein glycosylation in cancers and its potential therapeutic applications in neuroblastoma.
Ho WL; Hsu WM; Huang MC; Kadomatsu K; Nakagawara A
J Hematol Oncol; 2016 Sep; 9(1):100. PubMed ID: 27686492
[TBL] [Abstract][Full Text] [Related]
10. Discovery of sialyl Lewis A and Lewis X modified protein cancer biomarkers using high density antibody arrays.
Rho JH; Mead JR; Wright WS; Brenner DE; Stave JW; Gildersleeve JC; Lampe PD
J Proteomics; 2014 Jan; 96():291-9. PubMed ID: 24185138
[TBL] [Abstract][Full Text] [Related]
11. Identifying N-Glycan Biomarkers in Colorectal Cancer by Mass Spectrometry.
Sethi MK; Hancock WS; Fanayan S
Acc Chem Res; 2016 Oct; 49(10):2099-2106. PubMed ID: 27653471
[TBL] [Abstract][Full Text] [Related]
12. Use of the serum glycan state to predict ovarian cancer patients' clinical response to chemotherapy treatment.
Zhao R; Lin G; Wang Y; Qin W; Gao T; Han J; Qin R; Pan Y; Sun J; Ren C; Ren S; Xu C
J Proteomics; 2020 Jul; 223():103752. PubMed ID: 32209427
[TBL] [Abstract][Full Text] [Related]
13. O-glycan recognition and function in mice and human cancers.
Cervoni GE; Cheng JJ; Stackhouse KA; Heimburg-Molinaro J; Cummings RD
Biochem J; 2020 Apr; 477(8):1541-1564. PubMed ID: 32348475
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanism for cancer-associated induction of sialyl Lewis X and sialyl Lewis A expression-The Warburg effect revisited.
Kannagi R
Glycoconj J; 2004; 20(5):353-64. PubMed ID: 15229399
[TBL] [Abstract][Full Text] [Related]
15. Gangliosides and Tumors.
Kannagi R; Cai BH; Huang HC; Chao CC; Sakuma K
Methods Mol Biol; 2018; 1804():143-171. PubMed ID: 29926407
[TBL] [Abstract][Full Text] [Related]
16. Mass spectrometric profiling reveals association of N-glycan patterns with epithelial ovarian cancer progression.
Chen H; Deng Z; Huang C; Wu H; Zhao X; Li Y
Tumour Biol; 2017 Jul; 39(7):1010428317716249. PubMed ID: 28681696
[TBL] [Abstract][Full Text] [Related]
17. Clinical utility of a serum glycome analysis in patients with colorectal cancer.
Takei D; Harada K; Nouso K; Miyahara K; Dohi C; Matsushita H; Kinugasa H; Hiraoka S; Nishimura SI; Okada H
J Gastroenterol Hepatol; 2022 Apr; 37(4):727-733. PubMed ID: 35064597
[TBL] [Abstract][Full Text] [Related]
18. Chemoenzymatic Synthesis of Tri-antennary N-Glycans Terminating in Sialyl-Lewis
Li T; Spruit CM; Wei N; Liu L; Wolfert MA; de Vries RP; Boons GJ
Chemistry; 2024 Jun; 30(32):e202401108. PubMed ID: 38567703
[TBL] [Abstract][Full Text] [Related]
19. Identification of potential glycan cancer markers with sialic acid attached to sialic acid and up-regulated fucosylated galactose structures in epidermal growth factor receptor secreted from A431 cell line.
Wu SL; Taylor AD; Lu Q; Hanash SM; Im H; Snyder M; Hancock WS
Mol Cell Proteomics; 2013 May; 12(5):1239-49. PubMed ID: 23371026
[TBL] [Abstract][Full Text] [Related]
20. Specific glycosylation of membrane proteins in epithelial ovarian cancer cell lines: glycan structures reflect gene expression and DNA methylation status.
Anugraham M; Jacob F; Nixdorf S; Everest-Dass AV; Heinzelmann-Schwarz V; Packer NH
Mol Cell Proteomics; 2014 Sep; 13(9):2213-32. PubMed ID: 24855066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
